Form D Explorer

Form C-U — Cytex Therapeutics, Inc.

0001665160-23-000144 · filed 2023-01-27 · via StartEngine Capital, LLC

Offering

Target: $10,000
Maximum: $1,070,000
Security type: Other
Price per security: $2.0000
Deadline: —
Oversubscription: Accepted

Issuer

Name: Cytex Therapeutics, Inc.
CIK: 1943908
Entity: Corporation
Jurisdiction: DE
Address: 2609 N. DUKE STREET, SUITE 303A
DURHAM, NC 27704
Phone: —

Most recent fiscal year financials

Total assets

$626,138

Cash

—

Short-term debt

$144,543

Long-term debt

—

Revenues

$1,836,602

COGS

$1,263,476

Taxes paid

—

Net income

$-22,653

Same issuer's Form D filings

D · 2025-01-10

$2M

View original on SEC EDGAR.